CMR Repeatability in STEMI

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Elisa McAlindon, University of Bristol
ClinicalTrials.gov Identifier:
NCT01468662
First received: November 7, 2011
Last updated: July 8, 2013
Last verified: July 2013
  Purpose

The investigators propose to conduct a study to measure the reproducibility of CMR parameters that have been used to predict outcome following PPCI: infarct size, left ventricular volumes, myocardial salvage, microvascular obstruction (MVO) and myocardial oedema.


Condition
STEMI

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cardiovascular Magnetic Resonance Scan Repeatability in ST Segment Elevation Myocardial Infarction

Resource links provided by NLM:


Further study details as provided by University of Bristol:

Estimated Enrollment: 40
Study Start Date: November 2011

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

ST segment elevation myocardial infarction

Criteria

Inclusion Criteria:

Participant may enter study if ALL of the following apply

  1. ST segment myocardial infarction as defined by ECG (by 2 contiguous limb leads with >1 mm ST-segment elevation, or >2 mm ST-segment elevation in contiguous precordial leads, or new LBBB) and > 20 minutes of cardiac chest pain
  2. Written informed consent

Exclusion Criteria:

Participant may not enter study if ANY of the following apply

  1. Contraindication to MRI (implanted pacemaker/ defibrillator, ferromagnetic metal implant/ injury, claustrophobia, obesity/ too large for CMR scanner)
  2. Known allergy to gadolinium
  3. Chronic atrial fibrillation
  4. Renal impairment with eGFR <30
  5. Cardiogenic shock
  6. Patients with special communication needs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01468662

Locations
United Kingdom
Bristol Heart Institute
Bristol, United Kingdom, BS2 8HW
Sponsors and Collaborators
University of Bristol
Investigators
Principal Investigator: Elisa McAlindon, BMBS University of Bristol
  More Information

No publications provided

Responsible Party: Elisa McAlindon, Cardiology Clinical Research Fellow, University of Bristol
ClinicalTrials.gov Identifier: NCT01468662     History of Changes
Other Study ID Numbers: Study 1569
Study First Received: November 7, 2011
Last Updated: July 8, 2013
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Myocardial Infarction
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on July 24, 2014